Alprazolam in Bipolar-I Depressions
- 2 January 1984
- journal article
- case report
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 4 (1), 40-42
- https://doi.org/10.1002/j.1875-9114.1984.tb03311.x
Abstract
In an open-label study of alprazolam in five bipolar-I depressed patients, three patients remitted completely, one failed to respond, and one responded transiently, based on the Hamilton Rating Scale and Beck Depression Inventory scores. Further studies of alprazolam as an antidepressant are warranted.Keywords
This publication has 6 references indexed in Scilit:
- Alprazolam: Pharmacokinetics, Clinical Efficacy, and Mechanism of ActionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1982
- Alprazolam (Xanax®, the Upjohn Company)Drug Intelligence & Clinical Pharmacy, 1981
- Benzodiazepines in Depressive DisordersArchives of General Psychiatry, 1978
- Research Diagnostic CriteriaArchives of General Psychiatry, 1978
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960